F. Paulin

995 total citations
14 papers, 826 citations indexed

About

F. Paulin is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, F. Paulin has authored 14 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Hematology. Recurrent topics in F. Paulin's work include Multiple Myeloma Research and Treatments (3 papers), Cancer-related Molecular Pathways (3 papers) and RNA and protein synthesis mechanisms (3 papers). F. Paulin is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Cancer-related Molecular Pathways (3 papers) and RNA and protein synthesis mechanisms (3 papers). F. Paulin collaborates with scholars based in United Kingdom, United States and France. F. Paulin's co-authors include Anne E. Willis, Mark Stoneley, Stephen A. Chappell, John Le Quesne, Christopher G. Proud, Alastair M. Thompson, Jane Loughlin, Kirsty O’Brien, Linda Campbell and Stuart H. Ralston and has published in prestigious journals such as Nucleic Acids Research, Oncogene and Current Biology.

In The Last Decade

F. Paulin

14 papers receiving 816 citations

Peers

Countries citing papers authored by F. Paulin

Since Specialization

Citations

This map shows the geographic impact of F. Paulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Paulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Paulin more than expected).

Fields of papers citing papers by F. Paulin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Paulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Paulin. The network helps show where F. Paulin may publish in the future.

Co-authorship network of co-authors of F. Paulin

This figure shows the co-authorship network connecting the top 25 collaborators of F. Paulin. A scholar is included among the top collaborators of F. Paulin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Paulin. F. Paulin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer 2012 ·British Journal of Cancer ·Patricia Kelly, F. Paulin, Douglas J. Lamont, Lee D. Baker, (unknown), (unknown), Alan J. Thompson	40
2	The aromatase inhibitor letrozole enhances the effect of doxorubicin and docetaxel in an MCF7 cell line model 2012 ·ZooKeys ·Mary O’Neill, F. Paulin, Julie A. Vendrell, (unknown), Alastair M. Thompson	9
3	Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy 2010 ·British Journal of Cancer ·Patricia Kelly, (unknown), Kermit K. Murray, F. Paulin, Douglas J. Lamont, Lee D. Baker, Stuart Suttie, (unknown), Alastair M. Thompson	22
4	Gene expression in colorectal neoplasia: modifications induced by tissue ischaemic time and tissue handling protocol 2009 ·Histopathology ·Susan E. Bray, F. Paulin, (unknown), (unknown), (unknown), David A. Levison, R. Steele, Neil M. Kernohan	41
5	MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism 2008 ·BMC Cancer ·F. Paulin, Mary O’Neill, (unknown), Andrew Cassidy, A Ashfield, (unknown), Alastair J. Munro, Lee D. Baker, Colin A. Purdie, David P. Lane, Alastair M. Thompson	40
6	Seliciclib (CYC202, R‐roscovitine) enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model 2008 ·International Journal of Cancer ·(unknown), Mary O’Neill, Karen Murray, F. Paulin, Susan E. Bray, Neil M. Kernohan, David A. Levison, David P. Lane, Alastair M. Thompson	43
7	Tumor 18F-FDG incorporation is enhanced by attenuation of P53 function in breast cancer cells in vitro. 2006 ·PubMed ·Timothy Smith, (unknown), Alastair M. Thompson, F. Paulin	41
8	Evidence that the dephosphorylation of Ser535 in the ∊-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin 2002 ·Biochemical Journal ·Xuemin Wang, Maarten L. Janmaat, Anne Beugnet, F. Paulin, Christopher G. Proud	39
9	Eukaryotic translation initiation factor 5 (eIF5) acts as a classical GTPase-activator protein 2001 ·Current Biology ·F. Paulin, Linda Campbell, Kirsty O’Brien, Jane Loughlin, Christopher G. Proud	84
10	A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: A novel mechanism of oncogene de-regulation 2000 ·Oncogene ·Stephen A. Chappell, (unknown), F. Paulin, Matthew L. deSchoolmeester, Mark Stoneley, Richard Soutar, Stuart H. Ralston, Miep Helfrich, Anne E. Willis	111
11	C-Myc 5′ untranslated region contains an internal ribosome entry segment 1998 ·Oncogene ·Mark Stoneley, F. Paulin, John Le Quesne, Stephen A. Chappell, Anne E. Willis	289
12	A single nucleotide change in the c-myc internal ribosome entry segment leads to enhanced binding of a group of protein factors 1998 ·Nucleic Acids Research ·F. Paulin	23
13	Investigation of Aberrant Translational Control of c-myc in Cell Lines Derived from Patients with Multiple Myeloma 1997 ·Current topics in microbiology and immunology ·Anne E. Willis, F. Paulin, Michelle J. West, (unknown)	7
14	Aberrant translational control of the c-myc gene in multiple myeloma. 1996 ·PubMed ·F. Paulin, Michelle J. West, (unknown), (unknown), Linden Lyne, Anne E. Willis	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact